Sequana Medical NV (XBRU:SEQUA) EBIT per Share : €-1.24 (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Sequana Medical NV EBIT per Share?

Sequana Medical NV's EBIT per Share for the six months ended in Jun. 2023 was €-0.56. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €-1.24.

During the past 3 years, the average EBIT per Share Growth Rate was -2.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was -15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sequana Medical NV's EBIT per Share or its related term are showing as below:

XBRU:SEQUA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -28.8 Med: -4.8 Max: -2.8
Current: -2.8

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Sequana Medical NV was -2.80% per year. The lowest was -28.80% per year. And the median was -4.80% per year.

XBRU:SEQUA's 3-Year EBIT Growth Rate is ranked worse than
59.86% of 725 companies
in the Medical Devices & Instruments industry
Industry Median: 5.9 vs XBRU:SEQUA: -2.80

Sequana Medical NV's EBIT for the six months ended in Jun. 2023 was €-14.10 Mil.

Sequana Medical NV EBIT per Share Historical Data

The historical data trend for Sequana Medical NV's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV EBIT per Share Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

-0.96

-1.14

-1.17

-1.24

-1.30

Sequana Medical NV Semi-Annual Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EBIT per Share	Get a 7-Day Free Trial									-0.63	-0.61	-0.61	-0.69	-0.56

Sequana Medical NV EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sequana Medical NV's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-29.496	/	22.770
=	-1.30

Sequana Medical NV's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

	EBIT per Share		(Q: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-14.1	/	25.308
=	-0.56

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.24

Sequana Medical NV (XBRU:SEQUA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Sequana Medical NV EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (XBRU:SEQUA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (XBRU:SEQUA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

2SE:Germany

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (XBRU:SEQUA) Headlines

No Headlines